Overview

Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of cisplatin plus intensity-modulated radiotherapy (IMRT) based on FDG-PET/CT after induction chemotherapy (IC) for locally advanced head and neck squamous cell carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Lithuanian University of Health Sciences
Treatments:
Cisplatin
Docetaxel
Fluorouracil